Нажмите на эту строку чтобы перейти к Новостям сайта "Русский врач"

Перейти
на сайт
журнала
"Врач"
Перейти на сайт журнала "Медицинская сестра"
Перейти на сайт журнала "Фармация"
Перейти на сайт журнала "Молекулярная медицина"
Перейти на сайт журнала "Вопросы биологической, медицинской и фармацевтической химии"

MYCOBIOTA AS PART MICROBIOTA: FEATURES METHODS OF STUDYING AT PRESENT

DOI: https://doi.org/10.29296/25877313-2019-11-01
Download full text PDF
Issue: 
11
Year: 
2019

N.S. Bagirova Dr.Sc. (Med.), Leading Research Scientist, Microbiological Laboratory, Federal State Budgetary Institution «N.N. Blokhin National Medical Research Center of Oncology» of the Ministry of Health of the Russian Federation (Moscow) E-mail: nbagirova@mail.ru N.V. Dmitrieva Dr.Sc. (Med.), Professor, Head of the Microbiological Laboratory, Federal State Budgetary Institution «N.N. Blokhin National Medical Research Center of Oncology» of the Ministry of Health of the Russian Federation (Moscow) E-mail: prof.ndmitrieva@mail.ru I.N. Petukhova Dr.Sc. (Med.), Leading Research Scientist, Microbiological Laboratory, Federal State Budgetary Institution «N.N. Blokhin National Medical Research Center of Oncology» of the Ministry of Health of the Russian Federation (Moscow) E-mail: irinapet@list.ru Z.V. Grigoryevskaya Dr.Sc. (Med.), Senior Research Scientist, Microbiological Laboratory, Federal State Budgetary Institution «N.N. Blokhin National Medical Research Center of Oncology» of the Ministry of Health of the Russian Federation (Moscow) E-mail: izlatadoc@list.ru I.V. Tereshchenko Junior Research Scientist, Microbiological Laboratory, Federal State Budgetary Institution «N.N. Blokhin National Medical Research Center of Oncology» of the Ministry of Health of the Russian Federation (Moscow) E-mail: in.ter68@inbox.ru

The correct formation of the design of future research determines the representativeness of the results. Today, most studies are mainly focused on the study of the bacterial component of the human intestinal microbiota, and its fungal component is not taken into account. The study of intestinal mycobiota, which belongs to a diverse set of fungal species, is a relatively new and rapidly progressing field of study. Despite the ubiquity and abundance of fungi that inhabit the human intestines, their totality is several orders of magnitude smaller than bacteria. Recent studies, however, have shown that mycobiota can be closely associated with health and disease, that fungal communities not only change with the disease, but also play a role in maintaining homeostasis of a particular locus of the human body, as well as in influencing systemic immunity. In addition, it is now widely believed that the associations of fungi of various species in the host organism, the associations of bacteria and fungi are crucial for the health of the host. However, less than 0.4% of the literature is devoted to the study of mycobiota and mycobiomе. The mechanisms by which fungi interact with other components of the microbiome and host remain poorly characterized. The results of scientific research conducted for this purpose are often contradictory, and difficulties arise when trying to compare data. Researchers use different methods of obtaining material for research, different methods of studying its composition, diverse groups of patients (different geographical regions, without primary treatment, with treatment, different stages of the disease, etc.), often a small sample. Currently, a full-fledged study of mycobiomе is possible only with a multifaceted and multidisciplinary approach. An extremely interesting field of study is the functionality of various species of fungi, including how they interact with other eukaryotes and prokaryotes present in various loci of the human body. It remains to be seen, more importantly, how these interactions affect us.

Keywords: 
mycobiome
microbiome
mycobiota
microbiota
bacteriome

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Methe´ B.A., Nelson K.E., Pop M., Creasy H.H., Giglio M.G., Huttenhower C. et al. (248 collaborators: https://www.ncbi.
  2. nlm.nih.gov/pubmed/22699610). Human Microbiome Project Consortium.). A framework for human microbiome research // Nature. 2012; 486, 7402: 215–221. doi:10.1038/nature11209.
  3. Gillevet P.M., Sikaroodi M., Torzilli A.P. Analyzing salt-marsh fungal diversity: comparing ARISA fingerprinting with clone sequencing and pyrosequencing // Fungal Ecol. 2009; 2, 4: 160–167. doi: 10.1016/j.funeco. 2009.04.001.
  4. Forbes J.D., Bernstein C.N., Tremlett H., Van Domselaar G., Knox N.C. A Fungal World: Could the Gut Mycobiome Be Involved in Neurological Disease? // Front. Microbiol. 2019; 9: 3249. doi: 10.3389/fmicb. 2018.03249.
  5. Hernández-Santos N., Klein B.S. Through the scope darkly: the gut mycobiome comes into focus // Cell Host. Microbe. 2017; 22, 6: 728–729. doi: 10.1016/j.chom.2017.11.013.
  6. Huseyin C.E., O’Toole P.W., Cotter P.D., Scanlan P.D. Forgotten fungi - the gut mycobiome in human health and disease // FEMS Microbiol. Rev. 2017; 41, 4: 479–511. doi: 10.1093/femsre/fuw047.
  7. Griffith G.W., Ozkose E., Theodorou M., Davies D.R. Diversity of anaerobic fungal populations in cattle revealed by selective enrichment culture using different carbon sources // Fungal Ecol. 2009; 2: 87–97. doi: 10.1016/j.funeco. 2009.01.005.
  8. Chen Y., Chen Z., Guo R., Chen N., Lu H., Huang S., Wang J., Li L. Correlation between gastrointestinal fungi and varying degrees of chronic hepatitis B virus infection // Diagn. Microbiol. Infect. Dis. 2011; 70, 4: 492–498. doi: 10.1016/j.diagmicrobio. 2010.04.005.
  9. Hamad I., Sokhna C., Raoult D., Bittar F. Molecular detection of eukaryotes in a single human stool sample from Senegal // PLoS One. 2012; 7, 7: e40888. doi: 10.1371/journal.pone.0040888.
  10. Gouba N., Raoult D., Drancourt M. Plant and fungal diversity in gut microbiota as revealed by molecular and culture investigations // PLoS One 2013; 8, 3: e59474. doi:10.1371/journal.pone.0059474.
  11. Proal A.D., Albert P.J., Marshall T.G. Autoimmunity, and Vitamin D. CHAPTER 10 in «Infection and Autoimmunity», Second Edition. Edited by Yehuda Shoenfeld, Nancy Agmon-Levin, Noel R. Rose; p.163-182, Elsevier B.V, 2015. http://dx.doi.org/10.1016/B978-0-444-63269-2.00007-6.
  12. Hall R.A., Noverr M.C. Fungal interactions with the human host: exploring the spectrum of symbiosis // Curr. Opinion Microbiol. 2017; 40: 58–64. http://dx.doi.org/10.1016/j.mib. 2017.10.020.
  13. Duplishcheva A.P., Sinilova N.G., Tolkachev O.N., YAhontova L.D. Izuchenie vliyaniya nekotoryh alkaloidov na nespecificheskuyu rezistentnost' k infekcii // Sb. nauch. trudov «Himiya, tekhnologiya, medicina». Materialy Mezhdunar. konf., posvyashch. 75-letiyu VILAR. M. 27–29 iyunya 2006. T. XVII. S. 106–109.
  14. Berezhinskaya V.V., Nikitina S.S., Trutneva E.A. Protivovospalitel'nye svojstva alkaloidov tetrandrina, cikleanina i dauricina // Lekarstvennye rasteniya. Farmakologiya i himioterapiya. Trudy VILAR. M.: Kolos. 1971. T. 14. S. 43–58.
  15. Berezhinskaya V.V., Nikitina S.S. O protivovospalitel'nom ehffekte tetrandrina, i nekotoryh storonah ego mekhanizme dejstviya // Farmakologiya i toksikologiya. 1965. № 1. S. 77–81.
  16. Nikitina S.S., Trutneva E.A. K farmakologii alkaloida cikleanina // Farmakologiya i toksikologiya. 1967. T. 30. № 3. S. 332–334.
  17. Najdovich L.P., Trutneva E.A., Tolkachev O.N., Vasil'eva V.D. Himicheskij sostav otechestvennyh vidov semejstv Berberidaceae. Vzaimosvyaz' himicheskoj struktury i farmakologicheskoj aktivnosti // Farmaciya. 1976. № 4. S. 33–37.
  18. Kupchan S. Recent advances in the chemistry of tumor inhibitors of plant origin // Izvest. Otd. him. Nauki B"lg. Akad. Nauk, Sofiya. 1972. T. 5. № 2. S. 325–339. International Symposium on Natural Products. «Phytochemistry of the Balkan Flora». Varna. Bulgaria. Plenary Lecture. October 14–18 1971.
  19. Kupchan S.M., Liepa A.J., Baxter R.L., Hintz H.P.J. New alkaloids and related artifacts from Cyclea peltata // J. Org. Chem. 1973. V. 38. № 10. P. 1846–1852.
  20. Kupchan S.M., Altland H.W. Tumor inhibitors. 89. Structural requirements for tumor-inhibitory activity among bisbenzylisiquinoline alkaloids and related compounds // J. Medic. Chem. 1973. V. 16. № 8. P. 913–917.
  21. Barot V.M.R., Chang-Jung-Iieh, Farnsworth N.R., Forbes A., Guerra F., Han-Jui, Marini-Bettolo G.B., Natori S., Olweny C.L.M., Tella A., Tolkachev O.N. (Rep.), The structure–antitumor activity of some bisbenzylisoquinoline alkaloids // In: «Consultations on Potentials for Use of Plants Indicated by Traditional Medicine in Cancer Therapy». World Health Organization. Can/TRM/79.1, Geneva. 13–17 November 1978. Р. 8 (20).
  22. Tolkachev O.N. Issledovaniya v oblasti 1-benzilizohinolinovyh, bisbenzilizohinolinovyh i rodstvennyh alkaloidov: Avtoref. diss. … dokt. him. nauk. M.: MITHT. 1982. 369 s. Avtoreferat dissertacii, dokt. him. nauk, Moskva, MITHT, 1982. 50 s.
  23. Tolkachev O.N., Syrkin A.B. Molekulyarnye osnovy protivoopuholevoj aktivnosti bifunkcional'nyh alkaloidov // Pervyj s"ezd onkologov stran SNG. 3–6 dekabrya 1996. M. CHast' 1. S. 60.
  24. Tolkachev O.N., Vichkanova S.A., Makarova L.V., Najdovich L.P. Zavisimost' tuberkulostaticheskoj aktivnosti bisbenzilizohinolinovyh alkaloidov ot ih struktury // Farmaciya. 1978. T. 27. № 2. S. 23–26.
  25. Mitscher L.A., Wu W.-n., Doskotch R.W., Janes J., Beal J.L. Antibiotics from higher plants. Thalictrum rugosum // J. Chem. Soc. Chem. Commun. 1971. № 11. P. 589–590.
  26. Mitscher L.A., Wu W.-n., Doskotch R.W., Janes J., Beal J.L. Antimicrobial agents from higher plants. II. Alkaloids from Thalictrum rugosum // Lloidia. 1972, V. 35. № 2. P. 167–176.
  27. Zuguang Ye, Knox Van Dyke, Antimalarial Activity of Various Bisbenzylisoquinoline and Apor-phine-Benzylisoquinoline Alkaloids and their Structure-Activity Relationships against Chloroquine–Sensitive and Resistant Plasmodium falciparum Malaria in vitro // Malaria Control & Elimination. 2015. V. 5.
  28. № 1. P. 1–7.
  29. Ye Z. & Dyke K.V. Antimalarial activity of various bisbenzylisoquinoline and aporphine alkaloids and their structure-activity relationships against chlorochine sensitive and resistant plasmodium falciparum malaria in vitro // Malaria Contr. Elimination. 2015. V. 4. P. 137–147.
  30. Tolkachev O.N. Prirodnye diarilovye ehfiry // Himiya prirodnyh soedinenij. 1981. № 3. S. 263–283.
  31. Vichkanova S.A., Tolkachev O.N., Adgina V.V., Izosimova S.V., Goryunova L.V., SHipulina L.D. Vzaimosvyaz' mezhdu strukturoj i antimikrobnoj aktivnost'yu zameshchennyh ω-nitrostirolov // Farmakologiya i toksikologiya. 1975. T. 38. № 1. S. 71–77.
  32. Rubinchik M.A., Tolkachev O.N. Izuchenie antiprotozojnoj aktivnosti soedinenij ryada difenilovyh ehfirov i nekotoryh nitrostirolov // Medicinskaya parazitologiya i parazitarnye bolezni. 1976. T. 45. № 5. S. 531–536.
  33. Vichkanova S.A., Tolkachev O.N., Makarova L.V., Cizin YU.S. Struktura i protivotuberkuleznaya aktivnost' nekotoryh difenilovyh ehfirov // Farmakologiya i toksikologiya. 1974. T. 37, № 6. S. 711–715.
  34. Tumanyan M.A., Duplishcheva A.P., Sinilova N.G., Kirillicheva G.B., Solov'eva M.S., Tolkachev O.N. Immunostimuliruyushchee sredstvo (glaucina gidrohlorid) // Patent № 2032403 (RF), 10.04.1995 po zayavke № 4669907/14, prior. 30.03.1989. Byul. № 10.